The legacy PBMS, implemented in 2017, is the foundation for five PBMS modules that will be implemented in the CMES ecosystem.
What is staying the same?
The Opioid Risk module will remain with the current vendor, OpiSafe.
What is changing?
Four modules are being transitioned from the current vendor, Magellan, to a new vendor. The transition of the PBMS modules to MedImpact will enable flexibility, configurability, scalability, and interoperability for the pharmacy program. The modules transitioning from Magellan to MedImpact are:
- Pharmacy Benefit Management System
- Rebate
- Preferred Drug List
- Real-Time Benefit Tool
More information about each transition will be updated soon. The table below provides an overview of the PBMS modules and their anticipated changes.
Module | Current Vendor | New Vendor | Project Kickoff | Go Live |
|---|---|---|---|---|
Pharmacy Benefit Management System | Magellan | MedImpact | Spring 2024 | Fall 2025 |
Rebate | MedImpact | Spring 2024 | Fall 2025 | |
Preferred Drug List | MedImpact | Spring 2024 | Fall 2025 | |
Real-Time Benefit Tool | MedImpact | Spring 2024 | Fall 2025 | |
Opioid Risk | OpiSafe | OpiSafe | No Transition | |
Send questions or comments to hcpf_cmes@state.co.us.